Skip to main content

Table 2 RSV and URA hospitalizations at first year of follow-up

From: An epidemiological investigation of high-risk infants for Respiratory Syncytial Virus infections: a retrospective cohort study

 

BPD-RDS

CHD

PRETERM

Outcomes

N

Proportion

95% CI

N

Proportion

95% CI

N

Proportion

95% CI

RSV hospitalizations

23

2.1%

1.3

3.0

55

1.7%

1.2

2.1

86

2.2%

1.8

2.7

 with HCRU

12

52.2%**

31.8

72.6

19

34.5%

22.0

47.1

18

20.9%

12.3

29.5

URA hospitalizations

102

9.4%***

7.7

11.1

162

4.9%

4.2

5.7

206

5.4%

4.7

6.1

 with HCRU

30

29.4%*

20.6

38.3

31

19.1%

13.1

25.2

38

18.4%

13.1

23.7

  1. ***p<0.0001 for BPD-RDS cohort versus CHD and Preterm cohorts; **p<0.01 for BPD-RDS versus Preterm cohort; *p<0.05 for BPD-RDS cohort versus Preterm cohort (χ2 test)
  2. BPD Bronchopulmonary Dysplasia, RDS Respiratory Distress Syndrome, CHD Congenital Heart Diseases, RSV Respiratory Syncytial Virus, URA Undetermined Respiratory Agents, HCRU Health Care Resources Utilization, CI Confidence Intervals